New MRI dye shows promise in japanese patients
NCT ID NCT06010173
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed Phase 3 trial tested gadopiclenol, a new MRI contrast agent, in 240 Japanese adults and children with known or suspected lesions in the brain or body. The study compared a lower dose of gadopiclenol to a standard dose of gadobutrol to see if it could provide equally clear images. The goal was to improve MRI safety by using less contrast material.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- gadopiclenol (MRI contrast agent)
- What this could lead to
- If successful, this could confirm that a lower dose of gadopiclenol works as well as the standard contrast agent for MRI scans in Japanese patients.
- What could go wrong
- This is a completed Phase 3 trial, but results are not yet published. The study only included Japanese participants, so findings may not apply to other populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CNS LESION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fukuoka University Hospital
Fukuoka, 814-0180, Japan
-
Gifu University Hospital
Gifu, 501-1194, Japan
-
Gunma University Hospital
Gunma, 371-8511, Japan
-
Hamamatsu University Hospital
Shizuoka, 431-3192, Japan
-
Hiroshima City Hiroshima Citizens Hospital
Hiroshima, 730-8518, Japan
-
Jichi Medical University Hospital
Tochigi, 329-0498, Japan
-
Kanagawa Children's Medical Center
Kanagawa, 232-0066, Japan
-
Kawasaki Medical School Hospital
Okayama, 701-0192, Japan
-
Kobe City Medical Center General Hospital
Kobe, 650-0047, Japan
-
Kurobe City Hospital
Toyama, 938-8502, Japan
-
Kyoto City Hospital
Kyoto, 604-8845, Japan
-
Meitetsu Hospital
Aichi, 451-8511, Japan
-
Nakamura Memorial Hospital
Hokkaido, 060-8570, Japan
-
Nara Medical University Hospital
Nara, 634-8522, Japan
-
National Center for Child Health and Development
Tokyo, 157-8535, Japan
-
National Hospital Organization Shikoku Medical Center for Children and Adults
Kagawa, 765-8507, Japan
-
Osaka Metropolitan University Hospital
Osaka, 545-8586, Japan
-
Saitama Prefectural Children's Medical Center
Saitama, 330-8777, Japan
-
Shin-Kuki General Hospital
Saitama, 346-0021, Japan
-
Shizuoka General Hospital
Shizuoka, 420-8527, Japan
-
Toho University Omori Medical Center
Tokyo, 143-8541, Japan
-
Tohoku University Hospital
Miyagi, 980-8574, Japan
-
Tokyo Metropolitan Children's Medical Center
Tokyo, 183-8561, Japan
-
Tokyo Shinagawa Hospital
Tokyo, 140-8522, Japan
-
Tominaga Hospital
Osaka, 556-0017, Japan
-
University Hospital, Kyoto Prefectural University of Medicine
Kyoto, 602-8566, Japan
-
Yamaguchi University Hospital
Yamaguchi, 755-8505, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.